PANCREATOBILIARY CANCERS

Clinical trials for PANCREATOBILIARY CANCERS explained in plain language.

Never miss a new study

Get alerted when new PANCREATOBILIARY CANCERS trials appear

Sign up with your email to follow new studies for PANCREATOBILIARY CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a new targeted drug boost Chemotherapy's power against pancreatic cancer?

Disease control Not yet recruiting

This phase 2 trial is testing whether adding an investigational drug called telisotuzumab adizutecan to standard chemotherapy can help people with pancreatobiliary cancers, including pancreatic ductal adenocarcinoma. Participants will receive either the new combination or standar…

Matched conditions: PANCREATOBILIARY CANCERS

Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control

Last updated Aug 19, 2026 10:00 UTC

PANCREATOBILIARY CANCERS

Get alerted when new PANCREATOBILIARY CANCERS trials appear

Can a new targeted drug boost Chemotherapy's power against pancreatic cancer?